ARTEGRAFT

artegraft-logo

Artegraft processes and sells biologic vascular grafts derived from bovine carotid arteries and implanted primarily in hemodialysis patients.

#Website #More

ARTEGRAFT

Industry:
Medical Device

Founded:
1993-01-01

Address:
North Brunswick, New Jersey, United States

Country:
United States

Website Url:
http://www.artegraft.com

Total Employee:
11+

Status:
Active

Technology used in webpage:
SPF Amazon Microsoft Exchange Online Office 365 Mail GoDaddy DNS AWS Global Accelerator Vimeo GoDaddy Email


Official Site Inspections

http://www.artegraft.com

  • Host name: aec037177372cc6cd.awsglobalaccelerator.com
  • IP address: 15.197.225.128
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Artegraft"

Artegraft - Crunchbase Company Profile & Funding

Jun 22, 2020 Organization. Artegraft . Connect to CRM . Save . Summary. People. Technology. Signals & News. About. Artegraft offers surgeons a biological alternative to synthetic grafts. ... Artegraft is located in North โ€ฆSee details»

Artegraft - Ownership and Business Overview - Mergr

Jun 22, 2020 Artegraftโ€™s natural collagen matrix has proven long-term patency advantages over ePTFE and other synthetic graft materials. The company is also positioned as an alternative to โ€ฆSee details»

Artegraft Company Profile 2024: Valuation, Investors ... - PitchBook

Artegraft General Information Description. Manufacturer of bovine carotid artery grafts based in North Brunswick, New Jersey. The company's grafts consist of a biological fibrous matrix โ€ฆSee details»

Artegraft Company Profile - Office Locations, Competitors, โ€ฆ

Artegraft is a company that provides surgeons with a biological alternative to synthetic grafts. It offers a collagen matrix that is intended for use distal to the aorta as a segmental arterial โ€ฆSee details»

Artegraft, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Clinical Trials associated with Artegraft, Inc. NCT04146012 / Terminated Phase 3 Bovine Early Access, Compatibility and Hemostasis Post-Market Trial to Evaluate the Safety and โ€ฆSee details»

Artegraft - Products, Competitors, Financials, Employees, โ€ฆ

Artegraft processes and sells biologic vascular grafts that are derived from bovine carotid arteries and are implanted primarily in hemodialysis access patients. On June 22nd, 2020, Artegraft โ€ฆSee details»

Artegraft - Overview, News & Competitors | ZoomInfo.com

View Artegraft org chart to access information on key employees and get valuable insights about Artegraft organizational structure. The organizational chart highlights the reporting lines within โ€ฆSee details»

Artegraft Inc - Company Profile and News - Bloomberg Markets

Company profile page for Artegraft Inc including stock price, company news, executives, board members, and contact informationSee details»

Artegraft Inc - CAGE.report

Artegraft Inc. S.A.M. Registration: 6RZF5 [3683646] ARTEGRAFT INC : Company Details. Identification, Location & Contacts This profile was last updated: 04/01/2019 Status: ...See details»

Artegraft Inc - Company Details - medicalproductguide.com

Artegraft Inc 220 N Center Dr North Brunswick, NJ 08902 United States Phone:(732) 422-8333 Toll Free ... Email * First Name * Last Name * Organization Name * Profession * Professional โ€ฆSee details»

LeMaitre Acquires Artegraft

LeMaitre Vascular, Inc. (Nasdaq: LMAT) has acquired the business and assets of Artegraft, Inc. for $90.0 million, including $72.5 million in cash paid at closing ($65.0 million to Artegraft plus โ€ฆSee details»

LeMaitre Vascular acquires Artegraft - 2020-06-22 - Crunchbase

Jun 22, 2020 Artegraft Artegraft offers surgeons a biological alternative to synthetic grafts. Acquiring Organization: LeMaitre Vascular LeMaitre Vascular develops, manufactures, and โ€ฆSee details»

Artegraft CEO and Key Executive Team | Craft.co

Artegraft's President and CEO is Richard Gibson. Other executives include Cathleen Vanderveer, Senior VP; Norris Horn, Senior VP & Chief Financial Officer and 3 others. See the full โ€ฆSee details»

LeMaitre Vascular acquires Artegraft

Jul 2, 2020 Artegraft generated trade sales of US$15.6 million and estimated hospital-level sales of US$18.6 million during the twelve-month period ended 31 May 2020. Artegraftโ€™s unit sales โ€ฆSee details»

Artegraft - Qualifyze

Artegraft, Inc. is a producer of medical devices and equipment. This organization specializes in the fabrication and distribution of biological vascular grafts that originate from bovine carotid โ€ฆSee details»

Artegraft Inc - HealthManagement.org

Artegraft, Inc. was incorporated in January, 1993, upon the divestiture of the bovine vascular graft business from Johnson & Johnson.Artegraft was the first vascular graft approved by the FDA โ€ฆSee details»

Artegraft Revenue, Growth & Competitor Profile - IncFact.com

Nov 25, 2024 Trademark applications show the products and services that Artegraft is developing and marketing. Artegraft doesn't have any recent trademark applications, indicating โ€ฆSee details»

Artegraft, Inc. - North Brunswick, New Jersey (NJ)

Artegraft is a natural collagen vascular graft. Its biological fibrous matrix is processed to enhance long term patency and provide a tightly woven, cross-linked conduit that is flexible & compliant. โ€ฆSee details»

An Alternative Natural Vascular Access Graft - Transonic

Jan 16, 2019 A lesser know graft alternative is a bovine carotid artery graft (BCA) named Artegraft. 1 BCAโ€™s biological material consists of a flexible tightly woven, cross-linked fibrous โ€ฆSee details»

Artegraft® Collagen Vascular Graft - LeMaitre

The Journal of Vascular Access, Volume 15, No. 2, March-April 2014, Use of the Artegraft in Salvage of Arteriovenous Fistulas for Dialysis, Lesser DB. Journal of Vascular Surgery, โ€ฆSee details»